Rebecca Gelman

Rebecca Gelman

UNVERIFIED PROFILE

Are you Rebecca Gelman?   Register this Author

Register author
Rebecca Gelman

Rebecca Gelman

Publications by authors named "Rebecca Gelman"

Are you Rebecca Gelman?   Register this Author

90Publications

2116Reads

44Profile Views

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.

J Natl Cancer Inst 2018 08;110(8):863-870

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy001DOI Listing
August 2018

Brief Report: High Sensitivity and Specificity of the Cepheid Xpert HIV-1 Qualitative Point-of-Care Test Among Newborns in Botswana.

J Acquir Immune Defic Syndr 2017 08;75(5):e128-e131

*Harvard Medical School, Doris Duke International Clinical Research Fellowship, Boston, MA; †David Geffen School of Medicine, University of California, Los Angeles, CA; ‡Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; §Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; ‖Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA; and ¶Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503760PMC
August 2017

BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.

Mol Cell 2016 07 30;63(2):277-292. Epub 2016 Jun 30.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.cell.com/molecular-cell/pdf/S1097-2765(16)30224-6
Web Search
http://dx.doi.org/10.1016/j.molcel.2016.05.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982517PMC
July 2016

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

J Clin Oncol 2016 Mar 1;34(9):945-52. Epub 2016 Feb 1.

Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/28/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0343
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070554PMC
March 2016

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).

Breast Cancer Res Treat 2014 Jan 18;143(2):343-50. Epub 2013 Dec 18.

Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital and Harvard Medical School , Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2813-6DOI Listing
January 2014

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.

Breast Cancer Res Treat 2013 Oct 24;141(3):421-7. Epub 2013 Sep 24.

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2700-1DOI Listing
October 2013

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Breast Cancer Res Treat 2013 May 12;139(1):193-8. Epub 2013 Apr 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2375-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280061PMC
May 2013

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Clin Breast Cancer 2011 Dec 22;11(6):376-83. Epub 2011 Jun 22.

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2011.03.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773692PMC
December 2011

Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.

PLoS Pathog 2011 Dec 15;7(12):e1002436. Epub 2011 Dec 15.

Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1002436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240609PMC
December 2011

PIK3CA mutations in in situ and invasive breast carcinomas.

Cancer Res 2010 Jul 15;70(14):5674-8. Epub 2010 Jun 15.

Department of Cancer Biology, and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-08-2660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905503PMC
July 2010

Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer.

Cancer 2010 Apr;116(8):1879-86

Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24963DOI Listing
April 2010

Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.

Proc Natl Acad Sci U S A 2009 Mar 13;106(9):3372-7. Epub 2009 Feb 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0813306106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642666PMC
March 2009

Evaluating new CD4 enumeration technologies for resource-constrained countries.

Nat Rev Microbiol 2008 Nov;6(11 Suppl):S29-38

Department of Molecular Medicine and Haematology, University of the Witwatersrand and National Health Laboratory Services, 7 York Rd., Parktown, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
November 2008

Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy.

Breast J 2008 Jan-Feb;14(1):49-54

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2007.00522.xDOI Listing
February 2008

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.

Cancer 2007 Sep;110(5):965-72

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22885DOI Listing
September 2007

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.

Invest New Drugs 2007 Aug 8;25(4):369-75. Epub 2007 Mar 8.

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-007-9034-yDOI Listing
August 2007

Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.

Invest New Drugs 2007 Apr 13;25(2):161-4. Epub 2006 Sep 13.

Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9007-6DOI Listing
April 2007

Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity.

Int J Radiat Oncol Biol Phys 2007 Apr 1;67(5):1299-308. Epub 2007 Feb 1.

Joint Center for Radiation Therapy Residency Training Program, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160603512
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2006.11.026DOI Listing
April 2007

A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.

Int J Radiat Oncol Biol Phys 2006 Jul 5;65(4):1149-54. Epub 2006 Jun 5.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.02.006DOI Listing
July 2006

Germinal center function in the spleen during simian HIV infection in rhesus monkeys.

J Immunol 2006 Jul;177(2):1108-19

Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.177.2.1108DOI Listing
July 2006

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.

Int J Radiat Oncol Biol Phys 2006 Feb 21;64(2):496-504. Epub 2005 Oct 21.

Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.07.975DOI Listing
February 2006

Quality of life in a clinical trial of highly active antiretroviral therapy alone or with intravenous or subcutaneous interleukin-2 administration.

J Acquir Immune Defic Syndr 2005 Dec;40(4):428-33

The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.qai.0000182848.45722.b7DOI Listing
December 2005

Dose density in breast cancer: a simple message?

J Natl Cancer Inst 2005 Dec;97(23):1712-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji438DOI Listing
December 2005

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

Cancer Res 2005 Nov;65(21):9659-69

Department of Medical Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1663DOI Listing
November 2005

Offering participants results of a clinical trial: sharing results of a negative study.

Lancet 2005 Mar 12-18;365(9463):963-4

Department of Medical and Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(05)71085-0DOI Listing
April 2005

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.

J Clin Oncol 2005 Mar;23(9):1934-40

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.04.032
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.04.032DOI Listing
March 2005

Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.

Int J Radiat Oncol Biol Phys 2005 Feb;61(2):348-57

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.06.011DOI Listing
February 2005

Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.

Int J Radiat Oncol Biol Phys 2004 May;59(1):152-9

Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2003.10.029DOI Listing
May 2004

A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.

Cancer 2004 Apr;100(7):1358-64

Department of Radiation Oncology, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20136DOI Listing
April 2004

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.

Cancer Res 2003 May;63(9):2024-7

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
May 2003

Complementary medicine use among women enrolled in a genetic testing program.

Cancer Epidemiol Biomarkers Prev 2003 Apr;12(4):321-6

Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
April 2003

Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer.

J Cardiovasc Magn Reson 2002 ;4(2):265-71

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/jcmr-120003952DOI Listing
January 2003

BRCA1/2 genetic testing in the community setting.

J Clin Oncol 2002 Nov;20(22):4485-92

Department of Adult Oncology, Dana-Farber Cancer Institute, and Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.08.147DOI Listing
November 2002

Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Vaccine 2002 May;20(15):1934-7

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0264-410x(02)00072-5DOI Listing
May 2002

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Int J Radiat Oncol Biol Phys 2002 Feb;52(2):406-14

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(01)02661-xDOI Listing
February 2002